Skip to main content
Top
Published in: BMC Neurology 1/2018

Open Access 01-12-2018 | Research article

Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson’s disease

Authors: David Morley, Sarah Dummett, Laura Kelly, Ray Fitzpatrick, Crispin Jenkinson

Published in: BMC Neurology | Issue 1/2018

Login to get access

Abstract

Background

Comparisons between neurological conditions have the potential to inform service providers by identifying particular areas of difficulty experienced by affected individuals. This study aimed to identify predictors of activity and participation in people with motor neurone disease (MND), people with multiple sclerosis (MS) and people with Parkinson’s Disease (PD).

Methods

The Oxford Participation and Activities Questionnaire (Ox-PAQ) and Medical Outcomes Study 36-Item Short Form Survey (MOS SF-36) were administered by postal survey to 386 people with a confirmed diagnosis of MND, MS or PD. Data analyses focused on stepwise regression analyses in order to identify predictors of activity and participation in the three conditions assessed.

Results

Three hundred and thirty four participants completed the survey, a response rate of 86.5%. Regression analyses identified multiple predictors of activity and participation dependent on Ox-PAQ domain and disease group, the most prominent being social and physical functioning as measured by the MOS SF-36.

Conclusions

Results indicate that the physical and social consequences of neurological illness are of greatest relevance to people experiencing the conditions assessed. Whilst the largely inevitable physical implications of disease take hold, emphasis should be placed on the avoidance of social withdrawal and isolation, and the maintenance of social engagement should become a significant priority.
Literature
1.
go back to reference Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013;4:295–310.CrossRefPubMedPubMedCentral Gordon PH. Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 2013;4:295–310.CrossRefPubMedPubMedCentral
2.
go back to reference Noseworthy J, Lucchinetti M, Rodriguez M, Weinshenker B. Multiple sclerosis. N Engl J Med. 2000;343:938–52.CrossRefPubMed Noseworthy J, Lucchinetti M, Rodriguez M, Weinshenker B. Multiple sclerosis. N Engl J Med. 2000;343:938–52.CrossRefPubMed
3.
go back to reference Weinshenker B, Bass B, Rice G, Noseworthy J, Carriere W, Baskerville J, Ebers G. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989;112:133–46.CrossRefPubMed Weinshenker B, Bass B, Rice G, Noseworthy J, Carriere W, Baskerville J, Ebers G. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain. 1989;112:133–46.CrossRefPubMed
4.
go back to reference Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006;129(Pt 3):584–94.CrossRefPubMed Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006;129(Pt 3):584–94.CrossRefPubMed
6.
go back to reference Bloem B, Hausdorff J, Visser J, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004;19:871–84.CrossRefPubMed Bloem B, Hausdorff J, Visser J, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004;19:871–84.CrossRefPubMed
7.
go back to reference McCabe MP, Firth L, O'Connor E. A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings. 2009;16:355–62.CrossRefPubMed McCabe MP, Firth L, O'Connor E. A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings. 2009;16:355–62.CrossRefPubMed
8.
go back to reference McCabe MP, O'Connor EJ. Why are some people with neurological illness more resilient than others? Psychol Health Med. 2012;17:17–34.CrossRefPubMed McCabe MP, O'Connor EJ. Why are some people with neurological illness more resilient than others? Psychol Health Med. 2012;17:17–34.CrossRefPubMed
9.
go back to reference O'Connor EJ, McCabe MP. Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study. Qual Life Res. 2011;20:703–11.CrossRefPubMed O'Connor EJ, McCabe MP. Predictors of quality of life in carers for people with a progressive neurological illness: a longitudinal study. Qual Life Res. 2011;20:703–11.CrossRefPubMed
10.
go back to reference McCabe MP, Roberts C, Firth L. Satisfaction with services among people with progressive neurological illnesses and their carers in Australia. Nurs Health Sci. 2008;10:209–15.CrossRefPubMed McCabe MP, Roberts C, Firth L. Satisfaction with services among people with progressive neurological illnesses and their carers in Australia. Nurs Health Sci. 2008;10:209–15.CrossRefPubMed
11.
go back to reference McCabe MP, O'Connor EJ. A longitudinal study of economic pressure among people living with a progressive neurological illness. Chronic Illn. 2009;5:177–83.CrossRefPubMed McCabe MP, O'Connor EJ. A longitudinal study of economic pressure among people living with a progressive neurological illness. Chronic Illn. 2009;5:177–83.CrossRefPubMed
12.
go back to reference McCabe MP, Roberts C, Firth L. Work and recreational changes among people with neurological illness and their caregivers. Disabil Rehabil. 2008;30:600–10.CrossRefPubMed McCabe MP, Roberts C, Firth L. Work and recreational changes among people with neurological illness and their caregivers. Disabil Rehabil. 2008;30:600–10.CrossRefPubMed
13.
go back to reference O'connor EJ, McCabe MP, Firth L. The impact of neurological illness on marital relationships. J Sex Marital Ther. 2008;34:115–32.CrossRefPubMed O'connor EJ, McCabe MP, Firth L. The impact of neurological illness on marital relationships. J Sex Marital Ther. 2008;34:115–32.CrossRefPubMed
14.
go back to reference Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. The Oxford participation and activities questionnaire: study protocol. Patient Relat Outcome Meas. 2014;5:1–6. Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. The Oxford participation and activities questionnaire: study protocol. Patient Relat Outcome Meas. 2014;5:1–6.
15.
go back to reference Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. Validation of the Oxford participation and activities questionnaire. Patient Relat Outcome Meas. 2016;7:73–80.CrossRefPubMedPubMedCentral Morley D, Dummett S, Kelly L, Dawson J, Fitzpatrick R, Jenkinson C. Validation of the Oxford participation and activities questionnaire. Patient Relat Outcome Meas. 2016;7:73–80.CrossRefPubMedPubMedCentral
16.
go back to reference World Health Organisation. International classification of functioning, disability & health. Geneva: World Health Organisation; 2001. World Health Organisation. International classification of functioning, disability & health. Geneva: World Health Organisation; 2001.
17.
go back to reference Kelly L, Jenkinson C, Dummett S, Dawson J, Fitzpatrick R, Morley D. Development of the Oxford participation & activities questionnaire: constructing an item pool. Patient Relat Outcome Meas. 2015;6:145–55.CrossRefPubMedPubMedCentral Kelly L, Jenkinson C, Dummett S, Dawson J, Fitzpatrick R, Morley D. Development of the Oxford participation & activities questionnaire: constructing an item pool. Patient Relat Outcome Meas. 2015;6:145–55.CrossRefPubMedPubMedCentral
18.
go back to reference Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I: conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I: conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
20.
go back to reference McDowell I. General health status and quality of life. In: McDowell I, editor. Measuring health: a guide to rating scales & questionnaires. 3rd ed. Oxford: Oxford University Press; 2006. p. 520–703.CrossRef McDowell I. General health status and quality of life. In: McDowell I, editor. Measuring health: a guide to rating scales & questionnaires. 3rd ed. Oxford: Oxford University Press; 2006. p. 520–703.CrossRef
21.
go back to reference Corp IBM. IBM SPSS statistics for windows, version 22.0. Armonk, NY: IBM Corp; 2013. Corp IBM. IBM SPSS statistics for windows, version 22.0. Armonk, NY: IBM Corp; 2013.
22.
go back to reference McLeod JE, Clarke DM. A review of psychosocial aspects of motor neurone disease. J Neurol Sci. 2007;258:4–10.CrossRefPubMed McLeod JE, Clarke DM. A review of psychosocial aspects of motor neurone disease. J Neurol Sci. 2007;258:4–10.CrossRefPubMed
23.
go back to reference Gibbons CJ, Thornton EW, Ealing J, Shaw PJ, Talbot K, Tennant A, Young CA, UKMND-QoL Group. Assessing social isolation in motor neurone disease: a rasch analysis of the MND social withdrawal scale. J Neurol Sci. 2013;334:112–8.CrossRefPubMedPubMedCentral Gibbons CJ, Thornton EW, Ealing J, Shaw PJ, Talbot K, Tennant A, Young CA, UKMND-QoL Group. Assessing social isolation in motor neurone disease: a rasch analysis of the MND social withdrawal scale. J Neurol Sci. 2013;334:112–8.CrossRefPubMedPubMedCentral
24.
go back to reference Giovannetti AM, Schiavolin S, Raggi A, Quintas R, Cerniauskaite M, Confalonieri P, Mantegazza R, Torri Clerici V, Antozzi C, Brenna G, Leonardi M. Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire. Int J Rehabil Res. 2016;39:339–45.CrossRefPubMed Giovannetti AM, Schiavolin S, Raggi A, Quintas R, Cerniauskaite M, Confalonieri P, Mantegazza R, Torri Clerici V, Antozzi C, Brenna G, Leonardi M. Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire. Int J Rehabil Res. 2016;39:339–45.CrossRefPubMed
25.
go back to reference Lysandropoulos AP, Havrdova E, ParadigMS Group. ‘Hidden’ factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol. 2015;22(Suppl 2):28–33.CrossRefPubMed Lysandropoulos AP, Havrdova E, ParadigMS Group. ‘Hidden’ factors influencing quality of life in patients with multiple sclerosis. Eur J Neurol. 2015;22(Suppl 2):28–33.CrossRefPubMed
27.
go back to reference Tur C. Fatigue management in multiple sclerosis. Curr Treat Options Neurol. 2016;186:26.CrossRef Tur C. Fatigue management in multiple sclerosis. Curr Treat Options Neurol. 2016;186:26.CrossRef
28.
go back to reference Feinstein A, Freeman J, Lo AC. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol. 2015;14:194–207.CrossRefPubMed Feinstein A, Freeman J, Lo AC. Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol. 2015;14:194–207.CrossRefPubMed
30.
go back to reference Calne SM. The psychosocial impact of late-stage Parkinson’s disease. J Neurosci Nurs. 2003;35:306–13.CrossRefPubMed Calne SM. The psychosocial impact of late-stage Parkinson’s disease. J Neurosci Nurs. 2003;35:306–13.CrossRefPubMed
31.
go back to reference Balestrino R, Martinez-Martin P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. J Neurol Sci. 2017;373:173–8.CrossRefPubMed Balestrino R, Martinez-Martin P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. J Neurol Sci. 2017;373:173–8.CrossRefPubMed
32.
go back to reference Goodarzi Z, Mrklas KJ, Roberts DJ, Jette N, Pringsheim T, Holroyd-Leduc J. Detecting depression in Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;87:426–37.CrossRefPubMedPubMedCentral Goodarzi Z, Mrklas KJ, Roberts DJ, Jette N, Pringsheim T, Holroyd-Leduc J. Detecting depression in Parkinson disease: a systematic review and meta-analysis. Neurology. 2016;87:426–37.CrossRefPubMedPubMedCentral
33.
go back to reference Maffoni M, Giardini A, Pierobon A, Ferrazzoli D, Frazzitta G. Stigma Experienced by Parkinson’s disease patients: a descriptive review of qualitative studies. Parkinsons Dis. 2017;2017:7203259.PubMedPubMedCentral Maffoni M, Giardini A, Pierobon A, Ferrazzoli D, Frazzitta G. Stigma Experienced by Parkinson’s disease patients: a descriptive review of qualitative studies. Parkinsons Dis. 2017;2017:7203259.PubMedPubMedCentral
35.
go back to reference Ma HI, Saint-Hilaire M, Thomas CA, Tickle-Degnen L. Stigma As a key determinant of health-related quality of life in Parkinson’s disease. Qual Life Res. 2016;25:3037–45.CrossRefPubMedPubMedCentral Ma HI, Saint-Hilaire M, Thomas CA, Tickle-Degnen L. Stigma As a key determinant of health-related quality of life in Parkinson’s disease. Qual Life Res. 2016;25:3037–45.CrossRefPubMedPubMedCentral
36.
go back to reference Hermanns M. The invisible and visible stigmatization of Parkinson’s disease. J Am Assoc Nurse Pract. 2013;25:563–6.PubMed Hermanns M. The invisible and visible stigmatization of Parkinson’s disease. J Am Assoc Nurse Pract. 2013;25:563–6.PubMed
37.
go back to reference Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson’s disease: the potential of a social relational approach to disablism. Parkinsons Dis. 2013;2013:608562.PubMedPubMedCentral Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson’s disease: the potential of a social relational approach to disablism. Parkinsons Dis. 2013;2013:608562.PubMedPubMedCentral
Metadata
Title
Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson’s disease
Authors
David Morley
Sarah Dummett
Laura Kelly
Ray Fitzpatrick
Crispin Jenkinson
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2018
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-018-1024-5

Other articles of this Issue 1/2018

BMC Neurology 1/2018 Go to the issue